These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6978331)

  • 1. Immunocytochemical detection of tumour markers in bone metastases from carcinoma of the breast.
    Gugliotta P; Botta G; Bussolati G
    Histochem J; 1981 Nov; 13(6):953-9. PubMed ID: 6978331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study.
    Lee AK; Rosen PP; DeLellis RA; Saigo PE; Gangi MD; Groshen S; Bagin R; Wolfe HJ
    Am J Clin Pathol; 1985 Dec; 84(6):687-96. PubMed ID: 3878077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous assays of cancer-associated antigens in various neoplastic disorders.
    Franchimont P; Zangerle PF; Nogarede J; Bury J; Molter F; Reuter A; Hendrick JC; Collette J
    Cancer; 1976 Dec; 38(6):2287-95. PubMed ID: 63315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological markers in human lung carcinoma: an immunopathological study of six antigens.
    Harach HR; Skinner M; Gibbs AR
    Thorax; 1983 Dec; 38(12):937-41. PubMed ID: 6198740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human breast cancer markers].
    Remennik LV
    Eksp Onkol; 1985; 7(4):3-8. PubMed ID: 2994992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and prognosis of breast lesions. Value of 3 immunological markers: fibronectin, carcinoembryonic antigen and bovine lactalbumin. Study of 40 cases].
    Canioni D; Kermarec J
    Arch Anat Cytol Pathol; 1984; 32(4):235-42. PubMed ID: 6508376
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of immunohistochemical markers with patient prognosis in breast carcinoma: a quantitative study.
    Barry JD; Koch TJ; Cohen C; Brigati DJ; Sharkey FE
    Am J Clin Pathol; 1984 Nov; 82(5):582-5. PubMed ID: 6093496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some immunobiochemical approaches for the detection of metastases.
    Neville AM
    Invasion Metastasis; 1982; 2(1):2-11. PubMed ID: 6203866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinoma.
    Hitchcock A; Ellis IO; Robertson JF; Gilmour A; Bell J; Elston CW; Blamey RW
    J Pathol; 1989 Oct; 159(2):129-34. PubMed ID: 2553906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers in breast and lung cancer.
    Coombes RC; Dearnaley DP; Ellison ML; Neville AM
    Ann Clin Biochem; 1982 Jul; 19 (Pt 4)():263-8. PubMed ID: 6127052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of clinical chemistry measurements in classifying patients with breast cancer.
    Statland BE; Winkel P
    Crit Rev Clin Lab Sci; 1982; 16(4):255-90. PubMed ID: 6749428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential pathological application of immunocytochemical methods to the detection of micrometastases.
    Sloane JP; Ormerod MG; Neville AM
    Cancer Res; 1980 Aug; 40(8 Pt 2):3079-82. PubMed ID: 7397703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative tumour marker levels in patients with breast cancer and their prognosis.
    van Dalen A
    Tumour Biol; 1990; 11(4):189-95. PubMed ID: 2371496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
    Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
    Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical demonstration of several tumour markers in neoplastic and preneoplastic states of the uterine mucosa.
    Hustin J
    Gynecol Obstet Invest; 1978; 9(1):3-15. PubMed ID: 81793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the variations in the levels of beta2-microglobulin and carcino-embryonic antigen in the breast cancer and malignant melanoma (author's transl)].
    Grenier J; Serrou B; Suquet P; Pujol H
    Pathol Biol (Paris); 1978 Sep; 26(6):371-2. PubMed ID: 83589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen.
    Dearnaley DP; Sloane JP; Ormerod MG; Steele K; Coombes RC; Clink HM; Powles TJ; Ford HT; Gazet JC; Neville AM
    Br J Cancer; 1981 Jul; 44(1):85-90. PubMed ID: 7020739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour markers in breast cancer.
    Cove DH; Woods KL; Smith SC; Burnett D; Leonard J; Grieve RJ; Howell A
    Br J Cancer; 1979 Nov; 40(5):710-8. PubMed ID: 92331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carcino-embryonic antigen (CEA) in bone-marrow metastases (author's transl)].
    Bezares RF; Cavagnaro FJ; Palmer LR; Díaz AE; Domenichini E
    Sangre (Barc); 1982; 27(1):7-14. PubMed ID: 7048588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.